3-[5-(2-氟苯基)-1,2,4-恶二唑-3-基]苯甲酸

3-[5-(2-氟苯基)-1,2,4-恶二唑-3-基]苯甲酸（CAS 775304-57-9）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

Ataluren is approved for use by the European Medicines Agency to treat Duchenne Muscular Dystrophy in patients aged 5 years and older who are able to walk. More specifically, ataluren is used in the small group of patients whose disease is caused by a specific genetic defect (called a ‘nonsense mutation’) in the dystrophin gene.M09 - Other drugs for disorders of the musculo-skeletal system

同义词与商品名

Ataluren; 775304-57-9; PTC124; PTC-124; 3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid; 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoic acid; Translarna; K16AME9I3V; Atalureno; DTXSID5046776; Benzoic acid, 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]-; DTXCID3026776; Benzoic acid, 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)-; atalurenum; RefChem:560297; M09AX03

已收录的法规名录

GHS notification summary	100% (2 / 2)

GHS 危害分类

GHS notification summary	100% (2 / 2)

This chemical does not meet GHS hazard criteria for 100% (2 of 2) of all reports.

Reported as not meeting GHS hazard criteria by 2 of 2 companies. For more detailed information, please visit ECHA C&L website.

公开数据库对它的描述

3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid · CAS 775304-57-9 · C15H9FN2O3. UNII K16AME9I3V.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。